BONGROS: Porous Carbonate Hydroxyapatite Bone Graft for Enhanced Bone Regeneration BONGROS is an advanced porous carbonate hydroxyapatite bone graft designed to facilitate bone regeneration in various clinical applications. Developed through extensive research and experimentation, it offers exceptional efficacy and performance in bone void filling and augmentation procedures. Key Features and Benefits: Closest Substance to Human Bone: BONGROS closely mimics the composition and structure of human bone, making it an ideal substitute for bone defects. Its similarity to natural bone allows for seamless integration and promotes optimal bone remodeling. Optimal Structure for Bone and Blood Vessel Growth: The unique porous structure of BONGROS promotes the ingrowth of bone and blood vessels, supporting enhanced tissue regeneration and improving the overall success of the grafting procedure. Standard Volume Extender for Osteoconduction: BONGROS acts as a volume extender, providing a scaffold for new bone growth through the process of osteoconduction. It helps to fill bony voids or gaps in the skeletal system, including the extremities, spine, pelvis, and intraoral/maxillofacial regions. Solid and Fast Bone Formation: The carbonated hydroxyapatite composition of BONGROS facilitates solid and rapid bone formation. It provides a favorable environment for bone cells to proliferate and differentiate, leading to efficient bone regeneration and healing. Indications: BONGROS is indicated for use in a variety of clinical scenarios, including: Sinus Lift Guided Bone Regeneration (GBR) Alveolar Ridge Preservation Research and Development: BONGROS has undergone rigorous testing and clinical trials conducted by the Department of Orthopedic Surgery and Department of Material Engineering at Seoul National University. Animal tests and clinical trials conducted over a span of 5 years at prestigious medical institutions, such as Seoul National University Dental Hospital, Seoul Asan Hospital, and Samsung Medical Center, have demonstrated its excellent clinical efficacy. The structural integrity and performance of BONGROS have gained recognition in the field of biomaterials. A paper published in Biomaterials in 2000 highlighted the structural characteristics of BONGROS, which have since been cited in over 129 scientific papers, making it a valuable reference for researchers in the field of synthetic bone graft materials. Specification: HAGM0025: BONGROS HAGM, 0.25g HAGM0050: BONGROS HAGM, 0.50g HAGL0025: BONGROS HAGL, 0.25g HAGL0050: BONGROS HAGL, 0.50g HAGL0100: BONGROS HAGL, 1.00g Research Information: The efficacy of porous hydroxyapatite bone chip as an extender of local bone graft in posterior lumbar interbody fusion. A prospective consecutive study of instrumented posterolateral lumbar fusion using synthetic hydroxyapatite (BONGROS-HA) as a bone graft extender. Early Result of Hydroxyapatite in Bone Defect after Operative Treatment of Benign Bone Tumor. BONGROS offers a reliable and innovative solution for bone grafting procedures, promoting efficient bone regeneration and optimal patient outcomes. Consultation with healthcare professionals and adherence to established clinical protocols are recommended for the proper utilization of BONGROS in specific clinical settings.
